This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cobra Biologics Limited. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Scott D Gorman: Innovator in Gene Therapy
Introduction
Scott D Gorman is a notable inventor based in Witney, GB. He has made significant contributions to the field of gene therapy through his innovative work. His expertise and dedication have led to the development of a unique system that enhances the stability of plasmids, which are crucial for various biotechnological applications.
Latest Patents
Scott D Gorman holds a patent for a system titled "Plasmid stabilization." This invention describes a novel method of repressor titration for the maintenance of a plasmid that is useful in gene therapy and the production of recombinant proteins. The system involves a transformed host cell containing a plasmid with an operator that can bind to a repressor expressed in trans. It also includes a first chromosomal gene encoding the repressor and a second chromosomal gene essential for cell growth. The plasmid is maintained in sufficient numbers to titrate the repressor, allowing for the expression of the essential gene and promoting cell growth. He has 1 patent to his name.
Career Highlights
Scott D Gorman is associated with Cobra Biologics Limited, where he applies his expertise in biotechnology and gene therapy. His work at the company has been instrumental in advancing the field and contributing to innovative solutions in genetic engineering.
Collaborations
Throughout his career, Scott has collaborated with notable colleagues, including Steven Geraint Williams and David J Sherratt. These collaborations have fostered a productive environment for innovation and research in the biotechnology sector.
Conclusion
Scott D Gorman is a prominent figure in the field of gene therapy, with a focus on plasmid stabilization. His contributions through patents and collaborations highlight his commitment to advancing biotechnological innovations. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile